Oncology Institute (TOI) Receivables - Other (2020 - 2025)
Oncology Institute (TOI) has disclosed Receivables - Other for 5 consecutive years, with $339000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other changed N/A year-over-year to $339000.0, compared with a TTM value of $339000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $346000.0, changed N/A over the prior year.
- Receivables - Other was $339000.0 for Q3 2025 at Oncology Institute, down from $346000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1.3 million in Q1 2022 and bottomed at $339000.0 in Q3 2025.
- Average Receivables - Other over 5 years is $607909.1, with a median of $499000.0 recorded in 2023.
- Peak annual rise in Receivables - Other hit 10.7% in 2023, while the deepest fall reached 66.54% in 2023.
- Year by year, Receivables - Other stood at $1.2 million in 2021, then crashed by 50.12% to $617000.0 in 2022, then dropped by 10.7% to $551000.0 in 2023, then tumbled by 37.21% to $346000.0 in 2024, then decreased by 2.02% to $339000.0 in 2025.
- Business Quant data shows Receivables - Other for TOI at $339000.0 in Q3 2025, $346000.0 in Q4 2024, and $368000.0 in Q1 2024.